ASTRO Virtual Meeting Center

Log-in / Create Account

Session Information

2010 Annual Meeting

Click here to go to the previous page

Head and Neck: Particle Therapy, Rare Tumors, Pathology and Misc.

Track : Poster Discussion

Program Code: PD07

Date: Tuesday, November 2, 2010

Time: 2:45 PM to 4:15 PM EST

Duration: 90 Minutes

Location: Room: 1 A

SPEAKER(S):

Click the plus sign to see more detailed information about each speaker.

Sharon Spencer, M.D., Professor, University of Alabama Medical Center

July 1987 - July 1989, Instructor/Fellow, Radiation Oncology, University of Alabama Hospitals, Birmingham, Alabama October 1989 - October 1997, Assistant Professor, Radiation Oncology, University of Alabama Hospitals, Birmingham, Alabama August 1995 - December 1997, Interim Clinical Coordinator of Radiation Oncology, University of Alabama Hospitals, Birmingham, Alabama October 1, 1997 - October 2004, Associate Professor, Radiation Oncology, University of Alabama Hospitals, Birmingham, Alabama February 1998 - Present, Clinical Director of Radiation Oncology, University of Alabama Hospitals, Birmingham, Alabama October 2004 - Present, Professor, Radiation Oncology, University of Alabama Hospitals, Birmingham, Alabama 1.Wu X, Shen S, Spencer S, Fiveash J, Duan J, Popple RA, Pareek P, Brezovich IA: Semi-Automatic Contouring for Respiratory Gating. Med Phys 2006; 33:2170. 2.Ahmed RS, Fiveash JB, Popple RA, Spencer SA, DeLosSantos JF: An IMRT technique to increase therapeutic ratio of breast irradiation in patients with early stage left breast cancer: limiting second malignancies. J Clin Oncol 2006; supplement. 3.Cerfolio RJ, Bryant AS, Scott E, Sharma M, Robert F, Spencer SA, Garver RI: Women with Pathologic Stage I, II, and III Non-Small Cell Lung Cancer have better Survival than Men. Chest December 2006; 130(6):1796-802. 4.Sawrie SM, Guthrie BL, Spencer SA, Nordal RA, Meredith RF, Markert JM, Gloud GA, Fiveash JB: Predictors of Distant Brain Recurrence for Patients with Newly Diagnosed Brain Metastases Treated wth Stereotactic Radiosurgery Alone. Int J Clin Oncol Biol Phys Jan. 2008. 5.Siddiqui F, Pajak TF, Watkins-Bruner, D, Konski AA, Coyne JC, Gwede CK, Garden AS, Spencer SA, Jones C, Movsas B: Pretreatment Quality of Life Predicts for Locoregional Control in Head and Neck Cancer Patients: A Radiation Therapy Oncology Group Analysis. Int J Radiat Oncol Bio Phys Feb. 2008. 6.Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, Rotman M, Meredith R, Ang K: The Final Report of RTOG 9610 A Mulit-Institutional Trial of Re-irradiation and Chemotherapy for Unresectable Recurrent Squamous Cell Carcinoma of the Head and Neck. Head and Neck March 2008; 30(3): 281-8. 7.Caudell JJ, Sawrie SM, Spencer SA, Desmond RA, Carroll WR, Peters GE, Nabell LM, Meredith RF, Bonner JA: Locoregionally Advanced Head and Neck Cancer Treated with Primary Radiotherapy: A Comparison of the Addition of Cetuximab or Chemotherapy and the Impact of Protocol Treatment. Int J Radiat Oncol Biol Phys. July 2008; 71(3): 676-681. 8.Caudell JJ, Sawrie SM, Spencer SA, Desmond RA, Carroll WR, Peters GE, Nabell LM, Meredith RF, Bonner JA: Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys, July 2008. 9.Garden AS, Harris J, Trotti A, Jones CU, Carrascosa L, Ching JD, Spencer SA, Forastiere A, Weber RS, Ang KK: Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (TROG 99-14). Int J Radiat Oncol Biol Phys. Aug 2008; 71(5): 1351-5.

Paul Busse, M.D., Ph.D., Massachusetts General Hospital

Audio Synchronized to PowerPoint

(Code: PD07)